KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Amortization of Deferred Charges: 2009-2020

Historic Amortization of Deferred Charges for Exact Sciences (EXAS) over the last 10 years, with Dec 2020 value amounting to -$49.9 million.

  • Exact Sciences' Amortization of Deferred Charges fell 79.00% to -$49.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$33.1 million, marking a year-over-year decrease of 89.11%. This contributed to the annual value of $7.1 million for FY2022, which is 6.64% up from last year.
  • Per Exact Sciences' latest filing, its Amortization of Deferred Charges stood at -$49.9 million for Q4 2020, which was down 4,545.15% from $1.1 million recorded in Q3 2020.
  • Exact Sciences' 5-year Amortization of Deferred Charges high stood at $14.6 million for Q1 2020, and its period low was -$49.9 million during Q4 2020.
  • Its 3-year average for Amortization of Deferred Charges is -$1.8 million, with a median of $1.1 million in 2020.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first plummeted by 433.33% in 2017, then spiked by 85,341.67% in 2018.
  • Exact Sciences' Amortization of Deferred Charges (Quarterly) stood at $12,000 in 2016, then slumped by 433.33% to -$40,000 in 2017, then surged by 25,427.50% to $10.1 million in 2018, then tumbled by 375.26% to -$27.9 million in 2019, then crashed by 79.00% to -$49.9 million in 2020.
  • Its last three reported values are -$49.9 million in Q4 2020, $1.1 million for Q3 2020, and $1.1 million during Q2 2020.